No Data
No Data
No Data
No Data
No Data
Barclays Sticks to Their Buy Rating for Amneal Pharmaceuticals (AMRX)
TipRanks04:45 ET
Amneal Pharmaceuticals: A Strong Buy on Robust Growth and Promising Pipeline
TipRanks19:25 ET
Earnings Call Summary | Amneal Pharmaceuticals(AMRX.US) Q1 2024 Earnings Conference
The following is a summary of the Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript:Financial Performance:Amneal Pharmaceuticals reported a Q1 2024 revenue of $659 million, an incre
moomoo AIMay 3 22:55 ET · Conference Call
Amneal Stock Climbs on Q1 Report, Opioid Settlement Update
Seeking AlphaMay 3 15:45 ET
Amneal Pharmaceuticals: A Strong Buy on Robust Q1 Performance and Promising IPX-203 Launch
TipRanksMay 3 14:15 ET
Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating
Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating.
MT NewswiresMay 3 14:11 ET
No Data
No Data